The blood and marrow transplant and cell therapy programme at Baylor Scott & White's Sammons Cancer Center in Dallas, treating blood cancers and blood disorders.
This is the blood and marrow transplant programme at the Baylor Scott & White Charles A. Sammons Cancer Center in Dallas, Texas, on the Baylor University Medical Center campus at 301 North Washington Avenue. It is a hospital department within a large non-profit health system, not a private clinic, and it treats blood cancers and blood disorders under standard oncology pathways.
The site states that the programme is one of the largest of its kind in the United States, that it has carried out about 6,000 transplants across 35 years, and that it performed the region's first adult marrow transplant in 1983. It describes reduced-intensity conditioning transplants for patients with other illnesses who could not tolerate full-intensity treatment, and transplants using minimally mismatched or haploidentical — half-matched, usually a family member — donors.
Alongside transplantation the programme offers immune effector cell therapies. The site names chimeric antigen receptor T-cell therapy (CAR-T, in which a patient's own T cells are genetically modified to attack cancer), tumour-infiltrating lymphocyte therapy for metastatic melanoma, natural killer cell therapy, T-cell receptor therapy, monoclonal antibodies and immune checkpoint inhibitors. It states that immune cells are taken from the patient, reprogrammed and multiplied in its own laboratory, then infused back, and that it was among the first providers in North Texas to offer commercial CAR-T treatment to adults. Access to clinical trials is mentioned.
This is a very different kind of provider from the private regenerative clinics that also appear in this directory. Blood and marrow transplantation and CAR-T are established, regulated cancer treatments delivered under oncology referral, normally billed to insurance, and the site does not offer cell therapy for joints, ageing or general wellness. The site does not state its accreditation status or publish prices.
The programme treats blood cancers and blood disorders, and names some specific diagnoses for its cell therapies.
The site describes haematopoietic stem cell transplantation from the patient or from a donor, and immune effector cell therapies in which the patient's own immune cells are reprogrammed and multiplied in the centre's laboratory before being infused back.
No individual transplant physician is named on the pages reviewed; the site refers to a team of blood and marrow transplant oncology specialists with more than 130 years of combined experience, affiliated with Texas Oncology, so a prospective patient would need to ask who would lead their care.
The programme is based on the Baylor University Medical Center campus in Dallas, within the Charles A. Sammons Cancer Center. The site describes inpatient transplant care supported by a dedicated outpatient infusion centre with twelve private treatment areas, an oncology evaluation and treatment centre for problems arising out of hours, an on-site laboratory in which immune cells are reprogrammed and grown, and transplant patient housing close to the medical centre for people travelling in for long treatment courses.
The site publishes no prices. Transplantation and approved cell therapies of this kind are normally delivered on oncology referral and billed to insurance or Medicare, but the pages reviewed make no statement about cover, financial counselling or self-pay costs; this would need to be raised with the centre.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.